Cramer's Mad Money CEO Interview: Dr. Stanley Crooke, Isis Pharmaceuticals (ISIS) from the Seeking alpha article
Cramer's Mad Money - 7 Things To Watch In The Week Ahead (5/23/14)
May. 25, 2014 6:18 AM ET | SA Editor Miriam Metzinger
CEO Interview: Dr. Stanley Crooke, Isis Pharmaceuticals (ISIS)
Isis Pharmaceuticals (ISIS) has been cut in half from its highs, but it rose recently on positive data. Unlike many other biotechs, Isis "trades on its pipeline, not pipe dreams," said Cramer. The technology uses RNA-based technology to treat rare conditions, and the company has 32 drugs. The stock is up 200% since Cramer spoke to the CEO Dr. Stanley Crooke in 2012, but it is now low enough to consider buying. The company received positive data on its anti-coagulant drug, and it has shown to be safe and effective. There are 6 drugs that Isis expects to get to the market by 2018. "We have a tremendously exciting pipeline," said Dr. Crooke. Cramer suggests taking a long-term position in Isis; "this is my kind of stock."
Read darkout's report of isis ceo in 1997. "We have a tremendously exciting pipeline." Crookee appears confused don't you agree. All isis exciting drugs from 1997 failed, insiders made off with the loot !